Lipid Metabolism
A section of Metabolites (ISSN 2218-1989).
Section Information
Aims
The “Lipid Metabolism” section accepts manuscripts of original research and high-quality reviews on all aspects of lipid metabolism, including lipoproteins, with a particular focus on biomarkers of risk. This section accepts research papers on the clinical significance of plasma lipid and lipoprotein alterations in acute and chronic diseases, including obesity, diabetes, and cardiovascular disease, with special interest regarding alterations related to cardiometabolic risk. In addition, research papers on the therapeutic modulation of plasma lipids and lipoproteins, including the role of lifestyle, nutraceuticals, and drugs, are also welcome, with novel therapeutic approaches being of particular interest. Finally, this section welcomes the submission of International Consensus Documents.
Scope
Topics of interest include, but are not limited to:
- Identification of novel risk biomarkers
- The clinical significance of plasma lipid and lipoprotein alterations
- The evaluation of novel biomarkers in acute and chronic diseases
- The role of lifestyle and nutraceuticals
- The role of novel therapeutic approaches in treating metabolic disease
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- The Role of Lipid Metabolism in Dyslipidemias and Atherosclerosis (Deadline: 5 February 2023)
- Metabolic Profile of Vasculitis and Arterial Hypertension (Deadline: 20 February 2023)
- The Effect of Adipose Tissue Microenvironment on Metabolic Disease (Deadline: 31 March 2023)
- Advances in Cholesterol and Lipid Metabolism II (Deadline: 30 April 2023)
- Plant Hormone Regulation and Lipid Metabolism (Deadline: 30 April 2023)
- Advances in Lipid Research in Dry Eye Disease (Deadline: 1 May 2023)
- Plant Lipid Metabolism Regulation and Response to Environmental Clues (Deadline: 28 May 2023)
- Lipid Biomarkers of Infectious Diseases (Deadline: 30 May 2023)
- Bioactive Lipids in Neuroinflammatory Diseases (Deadline: 31 May 2023)
- Lipid Expression and Metabolism Aberrations in Skin Diseases (Deadline: 30 June 2023)
- Advances in Diagnosis and Treatment of Cardiovascular and Metabolic Diseases (Deadline: 31 October 2023)